BROADCASTS.com

b'Pfizer needed the ability to perform rapid analysis on its set of real-world evidence (RWE) data to improve patient outcomes, but its existing platform could not scale and meet its objectives. Pfizer collaborated with Deloitte to transform its real-world data and analytics capabilities that maximize insights and avoid duplicative investments by migrating their existing RWE data and analytics environment to the AWS Cloud. Learn how these strategies for planning, executing, and validating the success of these capabilities helped position Pfizer to use the AWS Cloud environment as the cornerstone of its patient-centric analytics to expand and incorporate new AI/ML capabilities, such as Amazon SageMaker. This session is brought to you by AWS partner, Deloitte Consulting LLP.'